Detailed Analysis of the Medicines Patent Pool-ViiV Pediatric ARV License and Memorandum of Understanding
infojustice 2013-03-30
Summary:
Introduction: On February 27, the Medicines Patent Pool (MPP) and ViiV Healthcare UK Limited (ViiV) announced their License Agreement on an older antiretroviral (ARV), abacavir (ABC), for pediatric treatment only, in 118 countries where 98.7% of child living with HIV live. They also entered into a separate, non-binding Memorandum of Agreement (MoU), which promises collaboration [...]